相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。Synthetic Multivalent Glycopeptide-Lipopeptide Antitumor Vaccines: Impact of the Cluster Effect on the Killing of Tumor Cells
Hui Cai et al.
ANGEWANDTE CHEMIE-INTERNATIONAL EDITION (2014)
Arraying the post-translational glycoproteome (PTG)
Ola Blixt et al.
CURRENT OPINION IN CHEMICAL BIOLOGY (2014)
The development of synthetic antitumour vaccines from mucin glycopeptide antigens
Nikola Gaidzik et al.
CHEMICAL SOCIETY REVIEWS (2013)
Fully Synthetic Self-Adjuvanting Thioether-Conjugated GlycopeptideLipopeptide Antitumor Vaccines for the Induction of Complement-Dependent Cytotoxicity against Tumor Cells
Hui Cai et al.
CHEMISTRY-A EUROPEAN JOURNAL (2013)
'Multicopy Multivalent' Glycopolymer-Stabilized Gold Nanoparticles as Potential Synthetic Cancer Vaccines
Alison L. Parry et al.
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY (2013)
Design and Synthesis of Multifunctional Gold Nanoparticles Bearing Tumor-Associated Glycopeptide Antigens as Potential Cancer Vaccines
Raymond P. Brinas et al.
BIOCONJUGATE CHEMISTRY (2012)
The Mucin MUC4 and Its Membrane Partner ErbB2 Regulate Biological Properties of Human CAPAN-2 Pancreatic Cancer Cells via Different Signalling Pathways
Nicolas Jonckheere et al.
PLOS ONE (2012)
Immune recognition of tumor-associated mucin MUC1 is achieved by a fully synthetic aberrantly glycosylated MUC1 tripartite vaccine
Vani Lakshminarayanan et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2012)
Self-Adjuvanting Multicomponent Cancer Vaccine Candidates Combining Per-Glycosylated MUC1 Glycopeptides and the Toll-like Receptor 2 Agonist Pam(3)CysSer
Brendan L. Wilkinson et al.
ANGEWANDTE CHEMIE-INTERNATIONAL EDITION (2011)
Synthetic Antitumor Vaccines Containing MUC1 Glycopeptides with Two Immunodominant Domains-Induction of a Strong Immune Response against Breast Tumor Tissues
Nikola Gaidzik et al.
ANGEWANDTE CHEMIE-INTERNATIONAL EDITION (2011)
Seromic profiling of colorectal cancer patients with novel glycopeptide microarray
Johannes W. Pedersen et al.
INTERNATIONAL JOURNAL OF CANCER (2011)
Autoantibodies to aberrantly glycosylated MUC1 in early stage breast cancer are associated with a better prognosis
Ola Blixt et al.
BREAST CANCER RESEARCH (2011)
Synthetic Antitumor Vaccines from Tetanus Toxoid Conjugates of MUC1 Glycopeptides with the Thomsen-Friedenreich Antigen and a Fluorine-Substituted Analogue
Anja Hoffmann-Roder et al.
ANGEWANDTE CHEMIE-INTERNATIONAL EDITION (2010)
Cancer Biomarkers Defined by Autoantibody Signatures to Aberrant O-Glycopeptide Epitopes
Hans H. Wandall et al.
CANCER RESEARCH (2010)
Tumor-Associated MUC1 Tandem-Repeat Glycopeptide Microarrays to Evaluate Serum- and Monoclonal-Antibody Specificity
Ulrika Westerlind et al.
ANGEWANDTE CHEMIE-INTERNATIONAL EDITION (2009)
A Synthetic Vaccine Consisting of a Tumor-Associated Sialyl-T-N-MUC1 Tandem-Repeat Glycopeptide and Tetanus Toxoid: Induction of a Strong and Highly Selective Immune Response
Anton Kaiser et al.
ANGEWANDTE CHEMIE-INTERNATIONAL EDITION (2009)
Mucins in cancer: function, prognosis and therapy
Donald W. Kufe
NATURE REVIEWS CANCER (2009)
Varied presentation of the Thomsen-Friedenreich disaccharide tumor-associated carbohydrate antigen on gold nanoparticles
Andreas Sundgren et al.
CARBOHYDRATE RESEARCH (2008)
Structure, evolution, anal biology of the MUC4 mucin
Pallavi Chaturvedi et al.
FASEB JOURNAL (2008)
MUC4 is Upregulated in ovarian carcinoma effusions and differentiates carcinoma cells from mesothelial cell
Ben Davidson et al.
DIAGNOSTIC CYTOPATHOLOGY (2007)
Synthetic vaccines of tumor-associated glycopeptide antigens by immune-compatible thioether linkage to bovine serum albumin
Sven Wittrock et al.
ANGEWANDTE CHEMIE-INTERNATIONAL EDITION (2007)
Expression of mucins (MUC1, MUC2, MUC3, MUC4, MUC5AC and MUC6) and their prognostic significance in human breast cancer
EA Rakha et al.
MODERN PATHOLOGY (2005)
MUC4 expression is a novel prognostic factor in patients with invasive ductal carcinoma of the pancreas
M Saitou et al.
JOURNAL OF CLINICAL PATHOLOGY (2005)
Diagnostic value of MUC4 immunostaining in distinguishing epithelial mesothelioma and lung adenocarcinoma
K Llinares et al.
MODERN PATHOLOGY (2004)
Biomimetic synthesis of the tumor-associated (2,3)-sialyl-T antigen and its incorporation into glycopeptide antigens from the mucins MUC1 and MUC4
S Dziadek et al.
CHEMISTRY-A EUROPEAN JOURNAL (2004)